- Report
- October 2024
- 180 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- December 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- March 2025
- 250 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- July 2024
- 138 Pages
Global
From €2847EUR$2,999USD£2,402GBP
- Report
- April 2024
- 125 Pages
Global
From €3750EUR$3,950USD£3,163GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- July 2024
- 139 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- February 2025
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- September 2024
- 247 Pages
Global
From €2326EUR$2,450USD£1,962GBP
- Report
- October 2024
- 197 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 187 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 197 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 192 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 195 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 198 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 191 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 180 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 185 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 182 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 188 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP

The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more